{"id":"adjuvant-fl","safety":{"commonSideEffects":[{"rate":null,"effect":"Myelosuppression (neutropenia, thrombocytopenia)"},{"rate":null,"effect":"Mucositis"},{"rate":null,"effect":"Diarrhea"},{"rate":null,"effect":"Nausea and vomiting"},{"rate":null,"effect":"Hand-foot syndrome"}]},"_chembl":{"chemblId":"CHEMBL4650400","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"FL (fluorouracil/leucovorin) is a classic adjuvant chemotherapy combination where fluorouracil acts as an antimetabolite to inhibit DNA synthesis, and leucovorin (folinic acid) enhances its cytotoxic effects by stabilizing the fluorouracil-thymidylate synthase complex. When used as an adjuvant therapy, it aims to eliminate residual micrometastatic disease and potentially prime anti-tumor immune responses.","oneSentence":"Adjuvant FL is a fluorouracil and leucovorin combination chemotherapy regimen designed to enhance immune response and reduce recurrence in cancer patients.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T03:19:33.438Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Adjuvant treatment of colorectal cancer"},{"name":"Adjuvant treatment of gastric or gastroesophageal cancer (investigational)"}]},"trialDetails":[{"nctId":"NCT07492316","phase":"PHASE1","title":"RNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB)","status":"NOT_YET_RECRUITING","sponsor":"University of Florida","startDate":"2026-05-15","conditions":"Recurrent Medulloblastoma","enrollment":24},{"nctId":"NCT04573140","phase":"PHASE1","title":"A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Florida","startDate":"2021-12-13","conditions":"Adult Glioblastoma, High Grade Glioma, WHO Grade III or IV Malignant Glioma","enrollment":28},{"nctId":"NCT07033689","phase":"EARLY_PHASE1","title":"Feasibility Study of Suizenji, in Patients With Unresectable Pancreatic Ductal Adenocarcinoma (SUNRISE-II)","status":"NOT_YET_RECRUITING","sponsor":"SONIRE Therapeutics Inc.","startDate":"2025-12-01","conditions":"Pancreatic Cancer","enrollment":10},{"nctId":"NCT00807911","phase":"PHASE2","title":"Adjuvant Chemotherapy After Preoperative Chemoradiotherapy to Treat Rectal Cancer","status":"COMPLETED","sponsor":"Asan Medical Center","startDate":"2008-11-01","conditions":"Rectal Cancer","enrollment":322},{"nctId":"NCT02167321","phase":"PHASE2","title":"Rectal Cancer, Adjuvant Chemotherapy, FOLFOX(5-fluorouracil/Leucovorin/Oxaliplatin), Total Mesorectal Excision","status":"UNKNOWN","sponsor":"Yonsei University","startDate":"2014-12","conditions":"Locally Advanced Rectal Cancer","enrollment":90},{"nctId":"NCT01407978","phase":"NA","title":"Tolerability and Immunogenicity Study of FLUVAL P H1N1 Flu Vaccine of Omninvest in Children and Adolescents","status":"COMPLETED","sponsor":"Fluart Innovative Vaccine Ltd, Hungary","startDate":"2009-08","conditions":"Novel 2009 Influenza H1N1, Influenza, Human","enrollment":58}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":4,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["fluorouracil, leucovorin"],"phase":"phase_2","status":"active","brandName":"Adjuvant FL","genericName":"Adjuvant FL","companyName":"Asan Medical Center","companyId":"asan-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Adjuvant FL is a fluorouracil and leucovorin combination chemotherapy regimen designed to enhance immune response and reduce recurrence in cancer patients. Used for Adjuvant treatment of colorectal cancer, Adjuvant treatment of gastric or gastroesophageal cancer (investigational).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}